Sana Biotechnology (SANA) Accounts Payables (2020 - 2026)

Sana Biotechnology's Accounts Payables history runs 7 years deep, the most recent figure standing at $2.1 million for Q1 2026.

• In Q1 2026, Accounts Payables rose 114.66% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $2.1 million (up 114.66% YoY), while the FY2025 annual figure was $1.7 million, down 67.97% from the prior year.
• Accounts Payables came in at $2.1 million for Q1 2026 at Sana Biotechnology, up from $1.7 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $9.9 million in Q3 2023 to a low of $989000.0 in Q1 2025.
• A 5-year average of $3.6 million and a median of $3.1 million in 2022 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables jumped 161.14% in 2024 and slumped 83.77% in 2025, its largest moves.
• Sana Biotechnology's Accounts Payables stood at $2.9 million in 2022, then soared by 43.79% to $4.1 million in 2023, then increased by 26.83% to $5.2 million in 2024, then sank by 67.97% to $1.7 million in 2025, then increased by 27.2% to $2.1 million in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $2.1 million, $1.7 million, and $1.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison